A. A. DUNK

451 total citations
18 papers, 338 citations indexed

About

A. A. DUNK is a scholar working on Hepatology, Epidemiology and Molecular Biology. According to data from OpenAlex, A. A. DUNK has authored 18 papers receiving a total of 338 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hepatology, 5 papers in Epidemiology and 4 papers in Molecular Biology. Recurrent topics in A. A. DUNK's work include Liver Disease Diagnosis and Treatment (4 papers), Liver Disease and Transplantation (4 papers) and Hepatocellular Carcinoma Treatment and Prognosis (2 papers). A. A. DUNK is often cited by papers focused on Liver Disease Diagnosis and Treatment (4 papers), Liver Disease and Transplantation (4 papers) and Hepatocellular Carcinoma Treatment and Prognosis (2 papers). A. A. DUNK collaborates with scholars based in United Kingdom, Ireland and China. A. A. DUNK's co-authors include Howard C. Thomas, Sheila Sherlock, R P Walt, N. A. G. Mowat, Tadashi Ikeda, Massimo Pignatelli, W. J. Jenkins, T S Sinclair, Anna S. Lok and P W Brunt and has published in prestigious journals such as Gut, Journal of Hepatology and British journal of surgery.

In The Last Decade

A. A. DUNK

18 papers receiving 310 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A. A. DUNK United Kingdom	11	209	167	74	52	27	18	338
B Ringe Germany	13	172 0.8×	70 0.4×	207 2.8×	56 1.1×	46 1.7×	44	388
G. Sansoè Italy	11	124 0.6×	83 0.5×	44 0.6×	35 0.7×	35 1.3×	32	298
Kei Sawara Japan	14	316 1.5×	254 1.5×	118 1.6×	47 0.9×	31 1.1×	38	486
J. A. Traver Spain	11	100 0.5×	114 0.7×	59 0.8×	14 0.3×	23 0.9×	17	336
Barbezat Go New Zealand	8	248 1.2×	164 1.0×	233 3.1×	17 0.3×	16 0.6×	31	462
E. Calvo García Spain	3	300 1.4×	263 1.6×	168 2.3×	26 0.5×	19 0.7×	7	353
Gianni Testino Italy	11	213 1.0×	267 1.6×	95 1.3×	21 0.4×	48 1.8×	37	409
S Todo United States	8	124 0.6×	55 0.3×	462 6.2×	76 1.5×	52 1.9×	12	629
A. P. Gonzalez Germany	13	234 1.1×	71 0.4×	380 5.1×	20 0.4×	37 1.4×	26	494
J. Körber Germany	9	125 0.6×	185 1.1×	90 1.2×	12 0.2×	28 1.0×	11	411

Countries citing papers authored by A. A. DUNK

Since Specialization

Citations

This map shows the geographic impact of A. A. DUNK's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. A. DUNK with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. A. DUNK more than expected).

Fields of papers citing papers by A. A. DUNK

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. A. DUNK. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. A. DUNK. The network helps show where A. A. DUNK may publish in the future.

Co-authorship network of co-authors of A. A. DUNK

This figure shows the co-authorship network connecting the top 25 collaborators of A. A. DUNK. A scholar is included among the top collaborators of A. A. DUNK based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. A. DUNK. A. A. DUNK is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Rowe, P H, et al.. (1998). Restenting malignant oesophageal strictures. British journal of surgery. 85(2). 261–263. 14 indexed citations

DUNK, A. A., et al.. (1990). The value of flumazenil in the reversal of midazolam‐induced sedation for upper gastrointestinal endoscopy. Alimentary Pharmacology & Therapeutics. 4(1). 35–42. 10 indexed citations

DUNK, A. A., et al.. (1990). The safety and efficacy of tripotassium dicitrato bismuthate (De‐Nol) maintenance therapy in patients with duodenal ulceration. Alimentary Pharmacology & Therapeutics. 4(2). 157–162. 8 indexed citations

Moore, John W., A. A. DUNK, Joanne Crawford, et al.. (1989). Neuropsychological deficits and morphological MRI brain scan abnormalities in apparently healthy non-encephalopathic patients with cirrhosis. Journal of Hepatology. 9(3). 319–325. 57 indexed citations

DUNK, A. A. & Howard C. Thomas. (1988). Review: the treatment of hepatocellular carcinoma. Alimentary Pharmacology & Therapeutics. 2(3). 187–201. 3 indexed citations

DUNK, A. A., et al.. (1988). The effects of propranolol on hepatic encephalopathy in patients with cirrhosis and portal hypertension. Alimentary Pharmacology & Therapeutics. 2(2). 143–151. 9 indexed citations

Brook, M G, et al.. (1987). Human lymphoblastoid interferon does not increase survival when added to mitozantrone in the treatment of hepatocellular carcinomas. Alimentary Pharmacology & Therapeutics. 1(4). 315–320. 4 indexed citations

DUNK, A. A., David M. Novick, & Howard C. Thomas. (1987). Natural Killer Cell Activity in Hepatocellular Carcinoma: In Vitro and in Vivo Responses to Interferon. Scandinavian Journal of Gastroenterology. 22(10). 1245–1250. 17 indexed citations

DUNK, A. A., et al.. (1987). Hepatocellular Carcinoma and the Hepatitis B Virus: A Study of British Patients. QJM. 62(238). 109–16. 6 indexed citations

10.

Fowler, Martin, Chia‐Ming Chu, Peter Karayiannis, et al.. (1986). Integration of HBV-DNA may not be a prerequisite for the maintenance of the state of malignant transformation. Journal of Hepatology. 2(2). 218–229. 50 indexed citations

11.

DUNK, A. A., Tadashi Ikeda, Massimo Pignatelli, & Howard C. Thomas. (1986). Human lymphoblastoid interferon. Journal of Hepatology. 2(3). 419–429. 44 indexed citations

12.

DUNK, A. A., Philip J. Johnson, W M Melia, et al.. (1985). Mitozantrone as single agent therapy in hepatocellular carcinoma. Journal of Hepatology. 1(4). 395–404. 27 indexed citations

13.

DUNK, A. A., et al.. (1984). Mitoxantrone as single agent therapy in primary hepatocellular carcinoma. Gut. 25(10). 1131. 3 indexed citations

14.

Walt, R P, et al.. (1983). Precipitation of hepatic encephalopathy by propranolol in cirrhosis.. BMJ. 287(6392). 585.1–585. 36 indexed citations

15.

DUNK, A. A., et al.. (1983). The effect of ranitidine on the plasma clearance and hepatic extraction of indocyanine green in patients with chronic liver disease.. British Journal of Clinical Pharmacology. 16(2). 117–120. 18 indexed citations

16.

Burroughs, A K, R P Walt, A. A. DUNK, et al.. (1982). Effect of cimetidine on portal hypertension in cirrhotic patients.. BMJ. 284(6323). 1159–1160. 18 indexed citations

17.

DUNK, A. A., W. J. Jenkins, & Sheila Sherlock. (1982). Guillain-Barre syndrome associated with hepatitis A in a male homosexual. Sexually Transmitted Infections. 58(4). 269–270. 10 indexed citations

18.

DUNK, A. A., et al.. (1980). Reactive Arthritis following Asymptomatic Yersinia Infection. Scottish Medical Journal. 25(4). 327–328. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact